Pharmacogenetics in HIV therapy.

作者: Sonia Rodríguez-Nóvoa , Inmaculada Jiménez-Nacher , Pablo Barreiro , Vincent Soriano , Ana Rendón

DOI:

关键词:

摘要: Administration of standard doses most antiretroviral drugs results in significant variations plasma drug concentrations among different individuals, as well rates drug-associated toxicity. The reasons for the large interindividual variability levels are multifactorial, and involve differences gender metabolism, concomitant medications, compliance, underlying diseases, genetic factors. Pharmacogenetics is discipline that analyses basis variation body disposition drugs. One main goals to give grounds individualized therapy. majority pharmacogenetic traits so far have involved metabolism. An example this inherited pharmacokinetics pharmacodynamics such hydralazine or isoniazid. This due polymorphisms N-acetyltransferase-2 (NAT2) gene, which may split population into three categories: slow, intermediate, fast metabolizers. Pharmacogenetic studies conducted with antiretrovirals focused on metabolizing enzymes transporter proteins cell membrane. Herein, we review known be associated altered antiretrovirals, influence efficacy toxicity these

参考文章(66)
Aimee Paulussen, Karel Lavrijsen, Hilde Bohets, Jan Hendrickx, Peter Verhasselt, Walter Luyten, Frank Konings, Martin Armstrong, Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans. Pharmacogenetics. ,vol. 10, pp. 415- 424 ,(2000) , 10.1097/00008571-200007000-00005
Vural Ozdemir, Werner Kalow, Bing-Kou Tang, Andrew Paterson, Scott Walker, Laszlo Endrenyi, Angela Kashuba, Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics. ,vol. 10, pp. 373- 388 ,(2000) , 10.1097/00008571-200007000-00001
Heather J Ribaudo, Catia Marzolini, Todd Hulgan, David B Clifford, Richard B Kim, Edward P Acosta, Roy M Gulick, David W Haas, Camlin Tierney, Grant R Wilkinson, Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS. ,vol. 18, pp. 2391- 2400 ,(2004)
Thomas Lang, Kathrin Klein, Joachim Fischer, Andreas Nussler, Peter Neuhaus, Ute Hofmann, Michel Eichelbaum, Matthias Schwab, Ulrich Zanger, Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics. ,vol. 11, pp. 399- 415 ,(2001) , 10.1097/00008571-200107000-00004
K Ueda, D P Clark, C J Chen, I B Roninson, M M Gottesman, I Pastan, The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. Journal of Biological Chemistry. ,vol. 262, pp. 505- 508 ,(1987) , 10.1016/S0021-9258(19)75806-2
Ralf Winzer, Peter Langmann, Michael Zilly, Franz Tollmann, Jörg Schubert, Hartwig Klinker, Benedikt Weissbrich, No influence of the P-glycoprotein polymorphisms MDR1 G2677T/A and C3435T on the virological and immunological response in treatment naïve HIV-positive patients. Annals of Clinical Microbiology and Antimicrobials. ,vol. 4, pp. 3- 3 ,(2005) , 10.1186/1476-0711-4-3
Herbert Spring, Inka Leier, Jörg König, Yunhai Cui, Dietrich Keppler, Ulrike Buchholz, Drug Resistance and ATP-Dependent Conjugate Transport Mediated by the Apical Multidrug Resistance Protein, MRP2, Permanently Expressed in Human and Canine Cells Molecular Pharmacology. ,vol. 55, pp. 929- 937 ,(1999)
Arne Zibat, Elisabeth Hustert, Oliver Burk, Michel Eichelbaum, Regina Eiselt, Ilka Brehm, Christine Fuss, Romy Mueller, Ulrich Brinkmann, Elena Presecan-Siedel, Leszek Wojnowski, Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metabolism and Disposition. ,vol. 29, pp. 1454- 1459 ,(2001)
Joyce A. Goldstein, Diana Dai, Ernest Hodgson, Randy Rose, Jun Tang, Rachelle J. Bienstock, Harvey W. Mohrenweiser, Identification of Variants of CYP3A4 and Characterization of Their Abilities to Metabolize Testosterone and Chlorpyrifos Journal of Pharmacology and Experimental Therapeutics. ,vol. 299, pp. 825- 831 ,(2001)
G. A. Nemeth, L. S. Gan, D. D. Christ, A. E. Mutlib, S. P. Seitz, J. A. Markwalder, H. Chen, Identification and Characterization of Efavirenz Metabolites by Liquid Chromatography/Mass Spectrometry and High Field NMR: Species Differences in the Metabolism of Efavirenz Drug Metabolism and Disposition. ,vol. 27, pp. 1319- 1333 ,(1999)